ProSomnus, MonitAir Partner to Integrate OSA Remote Monitoring
The collaboration integrates data from the ProSomnus RPMO₂ into MonitAir’s platform to support longitudinal tracking.
The collaboration integrates data from the ProSomnus RPMO₂ into MonitAir’s platform to support longitudinal tracking.
This new subscription service gives parents a deeper understanding of their baby’s development, health, and sleep trends.
The FDA clearance expands the indications for the watch in the US as a medical device for use by adults in hospitals, clinics, long-term care facilities, and in the home.
Psychologists get surprising insights into their patients’ sleeplessness when they monitor them regularly.
Read MoreThe digital health platform combines remote physiologic monitoring, therapeutic monitoring, chronic care management, and compliance tracking into a unified solution.
Read MoreParents in the United Kingdom will soon have access to Owlet’s Dream Sock with UKCA certification.
Read MoreWith the clearance, the system is available for at-home monitoring of oxygen saturation, pulse rate, and skin temperature in babies without a prescription.
Read MoreAvailable over-the-counter, Dream Sock is designed for routine in-home monitoring of sleep, oxygen saturation, and pulse rate in infants.
Read MoreNonin Medical has partnered with Medixine to co-develop remote digital monitoring services for more patient-centric diagnoses of chronic conditions.
Read MoreThe dos and don’ts of enrolling sleep patients in revenue-producing RPM programs.
Read MoreA pilot study showed the technology can accurately, safely, and continuously monitor blood oxygen saturation, potentially providing ongoing assessment of the efficacy of oral appliance therapy.
Read MoreDallas-based startup Harbor has raised $3.7 million in a seed funding round, paving the way for the launch of its baby monitor and remote night nanny service.
Read MoreOwlet announced the launch and availability of Dream Sock and BabySat, two medical devices with recent clearances from the FDA.
Read MoreThe system—which provides continuous monitoring of oxygen saturation, pulse rate, and skin temperature—was cleared for prescription use with healthy and sick babies 0-18 months of age.
Read MoreThe US Food and Drug Administration has granted De Novo clearance to an over-the-counter, foot-worn medical pulse oximetry solution for infants.
Read MoreA new artificial intelligence-based mattress instantly adjusts to the individual’s health and warns them of potential health issues before they are aware of them.
Read MoreSibel Health released a new physiological monitoring platform with FDA-cleared wearable sensors for continuous sleep and vital signs monitoring designed specifically for clinical trials.
Read MoreThe US Food and Drug Administration has created a new Digital Health Advisory Committee to help the agency explore the complex, scientific, and technical issues related to digital health technologies.
Read More